Episodes

  • Rising Costs in Healthcare: The 2026 Pharmaceutical Price Increases and Their Implications

    Rising Costs in Healthcare: The 2026 Pharmaceutical Price Increases and Their Implications
    May 27 2026
    I n early 2026, pharmaceutical manufacturers announced list price increases on at least 350 brand-name medications, continuing a pattern that affects treatments for cancer, COVID-19, migraines, and other conditions despite policy efforts to enhance affordability. This episode examines the scope of these hikes, notable examples such as Pfizer’s adjustments to Ibrance and Comirnaty, and the broader context of Medicare negotiations that provide relief for select drugs. Listeners will gain insights into the economic drivers, patient impacts, and potential long-term consequences for healthcare access and innovation.100
    Show More Show Less
    5 mins
  • The Accidental Mind: Serendipity and the Birth of Modern Psychopharmacology part 2

    The Accidental Mind: Serendipity and the Birth of Modern Psychopharmacology part 2
    May 26 2026
    Part two In the mid-20th century, a handful of chance observations transformed psychiatry from an asylum-bound specialty into a medical field powered by effective drugs. This episode explores how chlorpromazine emerged from industrial dyes and surgical experiments, how imipramine and lithium were stumbled upon while chasing unrelated ideas, and how these discoveries reshaped our understanding of mental illness. Join us for a fascinating journey through scientific luck, keen observation, and the drugs that freed millions from institutional walls.1
    Show More Show Less
    5 mins
  • The Accidental Mind: Serendipity and the Birth of Modern Psychopharmacology part 1

    The Accidental Mind: Serendipity and the Birth of Modern Psychopharmacology part 1
    May 25 2026
    In the mid-20th century, a handful of chance observations transformed psychiatry from an asylum-bound specialty into a medical field powered by effective drugs. This episode explores how chlorpromazine emerged from industrial dyes and surgical experiments, how imipramine and lithium were stumbled upon while chasing unrelated ideas, and how these discoveries reshaped our understanding of mental illness. Join us for a fascinating journey through scientific luck, keen observation, and the drugs that freed millions from institutional walls.
    Show More Show Less
    4 mins
  • Curcumin: Turmeric’s Golden Promise for Blood Sugar and Mood – Evidence, Arguments For and Against

    Curcumin: Turmeric’s Golden Promise for Blood Sugar and Mood – Evidence, Arguments For and Against
    May 21 2026
    Explore the 2026 meta-analysis and supporting studies on curcumin for prediabetes, type 2 diabetes, depression, and anxiety, weighing compelling arguments in favor of its use against important limitations and counterpoints. We break down benefits like improved glycemic control and mood support alongside bioavailability issues, study flaws, safety concerns, and why it’s no miracle cure. This balanced episode includes a layman’s summary, real-world example, and practical guidance for anyone considering turmeric or supplements
    Show More Show Less
    6 mins
  • Dextromethorphan ( think cough syrup) for OCD: A Promising Glutamate-Targeted Augmentation Strategy?

    Dextromethorphan ( think cough syrup) for OCD: A Promising Glutamate-Targeted Augmentation Strategy?
    May 20 2026
    A small 2026 randomized controlled trial found that adding low-dose dextromethorphan (DXM, 15 mg twice daily) to ongoing SSRI treatment significantly reduced Yale-Brown Obsessive Compulsive Scale (Y-BOCS) scores in adults with SSRI-resistant OCD, dropping from about 26.6 to 16.3 over 12 weeks versus little change on placebo. Strengths include its double-blind, placebo-controlled design, strong statistical effect size, excellent tolerability with no reported side effects, and alignment with the glutamatergic hypothesis of OCD. Limitations center on the tiny sample size (n=40), single-center location in Iran, lack of secondary outcomes or long-term follow-up, and potential pharmacokinetic variability from SSRI interactions; broader evidence from meta-analyses of other glutamatergic agents supports the approach but calls for larger confirmatory trials.
    Show More Show Less
    7 mins
  • Antidepressants and Suicide Prevention: Lessons from Korea’s 2002 Prescription Restrictions

    Antidepressants and Suicide Prevention: Lessons from Korea’s 2002 Prescription Restrictions
    May 15 2026
    A recent study examines how South Korea’s 2002 limits on SSRI prescribing by primary care physicians coincided with a striking rise in national suicide rates. This episode reviews the Korean evidence alongside international research on antidepressant access and suicide trends, highlighting methodological strengths and limitations. It concludes with balanced policy implications for mental-health care that weigh risks of both overprescribing and restricted access.
    Show More Show Less
    8 mins
  • Silent Slip: How Medications Are Fueling Falls in Our Elderly

    Silent Slip: How Medications Are Fueling Falls in Our Elderly
    May 5 2026
    This episode explores the alarming link between common medications and falls among older adults, revealing how psychotropics and polypharmacy contribute to up to three-quarters of incidents in nursing homes. Drawing on key studies, it details high-risk drug classes and their mechanisms while offering practical prevention strategies like medication reviews and lifestyle interventions. Essential listening for families, caregivers, and healthcare professionals seeking to safeguard elderly independence and reduce preventable injuries.
    Show More Show Less
    5 mins
  • The Dangerous Tetrad: Mastering the Fatal Signs of Rigidity and Fever -case study

    The Dangerous Tetrad: Mastering the Fatal Signs of Rigidity and Fever -case study
    May 3 2026
    In the ER, seconds matter when identifying the "Dangerous Tetrad": rigidity, fever, autonomic instability, and altered mentation. This episode breaks down the clinical markers and pathophysiology of these life-threatening syndromes to help clinicians differentiate between NMS and Serotonin Syndrome. A must-listen for healthcare professionals looking to sharpen their diagnostic skills and improve patient outcomes in high-acuity settings.
    Show More Show Less
    5 mins